CIS Pharma’s solubilization technology comprising cyclosporine A has entered proof of concept phase

Bubendorf, Switzerland October 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates water-soluble formulations [...]

By | Oktober 1st, 2016|Cellophil, solubilization technology|0 Comments

CIS Pharma develops solubilization technology for hydrophobic drugs

Bubendorf, Switzerland, September 2015 -- CIS Pharma has engaged in a research program to develop a new technology platform that creates water-soluble formulations of highly hydrophobic drugs. The approach comprises [...]

By | September 1st, 2015|Cellophil, solubilization technology|0 Comments